COMMUNIQUÉS West-GlobeNewswire

-
Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory Board
30/11/2017 -
Catalyst Pharmaceuticals, Inc. Announces Closing of Previously Announced Public Offering
30/11/2017 -
The Delta Companies Promotes DeLibra Wesley to Executive VP of Operations
30/11/2017 -
Block Listing Update
30/11/2017 -
Title21 Health Solutions® to Showcase its BMT Software Solution 8.5 at the 2018 BMT Tandem Meeting
30/11/2017 -
VALNEVA Expands its Commercial Operations and Establishes US Infrastructure
30/11/2017 -
VALNEVA poursuit le développement de ses activités commerciales avec la mise en place d'une infrastructure aux Etats-Unis
30/11/2017 -
Hemostemix Drives Forward with Talented New Management into New Headquarters
30/11/2017 -
Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical
30/11/2017 -
Avivagen Announces Closing of Private Placement Totaling $4 million
30/11/2017 -
Sales of Olainfarm in Nine Months Reach 90.4 Million Euros
30/11/2017 -
BeyondSpring Initiates Global Phase 2/3 Trial with Plinabulin in China for the Prevention of Chemotherapy-Induced Neutropenia to Demonstrate Superiority
30/11/2017 -
BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study
30/11/2017 -
TearLab Launches Registered Direct Offering
30/11/2017 -
Symphony Health Launches New Long Term Care Channel Offering
30/11/2017 -
Scythian Biosciences Corp. Completes Sale of Go Green
30/11/2017 -
TOMI Environmental Solutions, Inc. Joins Forces With Protak Scientific in Ground Breaking Partnership
30/11/2017 -
RespireRx Pharmaceuticals Inc. Announces Publication of Phase 2B PACE Study: Once per Night Treatment with Dronabinol Provides Statistically Significant Improvement in Clinical Measures of Obstructive Sleep Apnea
30/11/2017 -
PDMR Dealing
30/11/2017
Pages